• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

处方药:肥胖的一个可改变的促成因素。

Prescription medications: a modifiable contributor to obesity.

作者信息

Cheskin L J, Bartlett S J, Zayas R, Twilley C H, Allison D B, Contoreggi C

机构信息

Department of Medicine, Johns Hopkins University School of Medicine, and Johns Hopkins Bayview Medical Center, Baltimore, MD 21224, USA.

出版信息

South Med J. 1999 Sep;92(9):898-904. doi: 10.1097/00007611-199909000-00009.

DOI:10.1097/00007611-199909000-00009
PMID:10498166
Abstract

BACKGROUND

While usually not the only factor in obese patients, prescription medications, which may increase appetite or body weight, can be important in some individuals. The cause of weight gain in such cases may go unrecognized or lead to cessation of medication with or without the practitioner's knowledge or approval.

METHODS

We found illustrative cases among patients treated at the Johns Hopkins Weight Management Center, searched MEDLINE and the Micromedex Drug Information database, and organized this information by drug mechanism and indications for use.

RESULTS

Most reports of medication-induced weight gain are anecdotal or gleaned from clinical trials. Notable offenders include hormones (especially corticosteroids and insulinotropic agents), and psychoactive medications (especially tricyclic antidepressants, lithium, and some antipsychotics).

CONCLUSIONS

Medication-related increases in appetite and body weight are under-recognized and cause noncompliance with pharmacotherapy. A high index of awareness of the known mechanisms by which medications can lead to weight gain has the potential to prevent most medication-related contributions to weight gain and obesity.

摘要

背景

虽然在肥胖患者中,处方药物通常并非导致肥胖的唯一因素,但那些可能增加食欲或体重的药物,对某些个体而言可能是重要因素。在此类情况下,体重增加的原因可能未被识别,或者可能在医生不知情或未批准的情况下导致停药。

方法

我们在约翰·霍普金斯体重管理中心治疗的患者中发现了一些典型病例,检索了MEDLINE和Micromedex药物信息数据库,并根据药物作用机制和使用指征对这些信息进行了整理。

结果

大多数关于药物导致体重增加的报告都是轶事性的,或者是从临床试验中收集而来的。值得注意的药物包括激素(尤其是皮质类固醇和促胰岛素分泌剂)以及精神活性药物(尤其是三环类抗抑郁药、锂盐和某些抗精神病药物)。

结论

与药物相关的食欲和体重增加未得到充分认识,并且会导致药物治疗依从性不佳。对药物导致体重增加的已知机制保持高度警惕,有可能预防大多数与药物相关的体重增加和肥胖问题。

相似文献

1
Prescription medications: a modifiable contributor to obesity.处方药:肥胖的一个可改变的促成因素。
South Med J. 1999 Sep;92(9):898-904. doi: 10.1097/00007611-199909000-00009.
2
[Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management].[精神药物所致体重增加:关于流行病学数据、机制及管理的文献综述]
Encephale. 2005 Jul-Aug;31(4 Pt 1):507-16. doi: 10.1016/s0013-7006(05)82412-1.
3
Bodyweight change as an adverse effect of drug treatment. Mechanisms and management.体重变化作为药物治疗的不良反应。机制与管理。
Drug Saf. 1996 May;14(5):329-42. doi: 10.2165/00002018-199614050-00005.
4
Psychiatric medication-induced obesity: a review.精神科药物所致肥胖:综述
Obes Rev. 2004 May;5(2):115-21. doi: 10.1111/j.1467-789X.2004.00139.x.
5
Pharmacotherapy for psychotropic drug-related weight gain.用于治疗精神药物所致体重增加的药物治疗
J Psychosoc Nurs Ment Health Serv. 2008 Jul;46(7):15-8. doi: 10.3928/02793695-20080701-06.
6
Weight considerations in psychotropic drug prescribing and switching.精神药物处方和换药中的体重考虑因素。
Postgrad Med. 2013 Sep;125(5):117-29. doi: 10.3810/pgm.2013.09.2706.
7
[Metabolic side effects of risperidone in early onset schizophrenia].[利培酮在早发性精神分裂症中的代谢副作用]
Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1.
8
Common Medications Which Lead to Unintended Alterations in Weight Gain or Organ Lipotoxicity.导致意外体重增加或器官脂毒性改变的常见药物。
Curr Gastroenterol Rep. 2016 Jan;18(1):2. doi: 10.1007/s11894-015-0479-4.
9
Drug-induced weight gain.药物性体重增加
Drugs Today (Barc). 2005 Aug;41(8):547-55. doi: 10.1358/dot.2005.41.8.893630.
10
'Why getting fat, Doc?' Weight gain and psychotropic medications.“医生,为什么我会发胖?”体重增加与精神类药物
Aust N Z J Psychiatry. 2001 Jun;35(3):315-21. doi: 10.1046/j.1440-1614.2001.00891.x.

引用本文的文献

1
Extensive Phenotyping for Potential Weight-Inducing Factors in an Outpatient Population with Obesity.肥胖门诊患者潜在致胖因素的广泛表型分析。
Obes Facts. 2019;12(4):369-384. doi: 10.1159/000499978. Epub 2019 Jun 19.
2
A comprehensive diagnostic approach to detect underlying causes of obesity in adults.一种全面的诊断方法,用于检测成年人肥胖的潜在原因。
Obes Rev. 2019 Jun;20(6):795-804. doi: 10.1111/obr.12836. Epub 2019 Mar 1.
3
Medications that cause weight gain and alternatives in Canada: a narrative review.加拿大导致体重增加的药物及其替代药物:一项叙述性综述
Diabetes Metab Syndr Obes. 2018 Aug 21;11:427-438. doi: 10.2147/DMSO.S171365. eCollection 2018.
4
Metabolomics Based Profiling of Dexamethasone Side Effects in Rats.基于代谢组学的大鼠地塞米松副作用分析
Front Pharmacol. 2018 Feb 16;9:46. doi: 10.3389/fphar.2018.00046. eCollection 2018.
5
Higher serum choline and betaine levels are associated with better body composition in male but not female population.血清胆碱和甜菜碱水平较高与男性而非女性人群的身体成分较好有关。
PLoS One. 2018 Feb 20;13(2):e0193114. doi: 10.1371/journal.pone.0193114. eCollection 2018.
6
Higher Dietary Choline and Betaine Intakes Are Associated with Better Body Composition in the Adult Population of Newfoundland, Canada.在加拿大纽芬兰的成年人群中,较高的膳食胆碱和甜菜碱摄入量与更好的身体组成相关。
PLoS One. 2016 May 11;11(5):e0155403. doi: 10.1371/journal.pone.0155403. eCollection 2016.
7
The association between diet and glucocorticoid treatment in patients with SLE.饮食与 SLE 患者糖皮质激素治疗的关系。
Lupus Sci Med. 2016 Jan 27;3(1):e000135. doi: 10.1136/lupus-2015-000135. eCollection 2016.
8
Common Medications Which Lead to Unintended Alterations in Weight Gain or Organ Lipotoxicity.导致意外体重增加或器官脂毒性改变的常见药物。
Curr Gastroenterol Rep. 2016 Jan;18(1):2. doi: 10.1007/s11894-015-0479-4.
9
Overweight and obesity in children and adolescents.儿童和青少年的超重与肥胖
J Clin Res Pediatr Endocrinol. 2014 Sep;6(3):129-43. doi: 10.4274/Jcrpe.1471.
10
Clinician uptake of obesity-related drug information: a qualitative assessment using continuing medical education activities.临床医生对肥胖相关药物信息的接受程度:使用继续医学教育活动进行的定性评估。
Nutr J. 2013 Apr 10;12:44. doi: 10.1186/1475-2891-12-44.